Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis
about
Current progress with Moraxella catarrhalis antigens as vaccine candidatesPanel 6: Vaccines.Intranasal immunization of the combined lipooligosaccharide conjugates protects mice from the challenges with three serotypes of Moraxella catarrhalis.Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.Preparation and Evaluation of a New Lipopolysaccharide-based Conjugate as a Vaccine Candidate for Brucellosis.Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B.Vaccine targets against Moraxella catarrhalis.Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination.Molecular aspects of Moraxella catarrhalis pathogenesis.Moraxella catarrhalis: from interactions with the host immune system to vaccine development.Molecular mechanisms of moraxella catarrhalis-induced otitis media.Potential impact of a Moraxella catarrhalis vaccine in COPD.A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: an update on current progress and challenges.Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera.Potential targets for next generation anti-microbial glycoconjugate vaccines.
P2860
Q28304447-CEB60085-C7D6-4E08-B894-B8578279E370Q33644678-E8075398-D16A-421A-BEC7-BDDF926ACEC1Q34117703-77F43448-11F2-4155-B94C-2A80777FF635Q35029651-77A5BD02-8C09-43D5-B2E6-1B36F69CE5ECQ35138009-A17D7E74-726D-4E01-9E80-FF2DF8A1C8FAQ35273041-AA10EE30-8FBC-47B8-9027-99CA1832F5BBQ36483998-D8954758-2B64-49E5-8451-B926A437C49EQ36845123-05021ED0-8D0B-4C19-A31D-6654D85F7682Q37590025-37282F28-ECF1-492C-8225-D7A9E9E9A2F8Q38041190-DDE17A45-E425-4BF8-BD1C-B752C9A4B628Q38128233-8AE20911-14E0-4B38-BACE-6F01C1859593Q39129692-A2C55C08-A7FA-4059-ADE7-526C34CD0B77Q40074756-7C741B04-90EF-4587-B499-D8D4AAE57277Q42601451-CAEA1ABD-65C0-49AC-A791-D4EE3F6BB0CBQ53701548-DABC2EE8-5D3E-4BBB-9CFA-BE3E40526BD8
P2860
Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Biological and immunological c ...... rotype C Moraxella catarrhalis
@ast
Biological and immunological c ...... rotype C Moraxella catarrhalis
@en
Biological and immunological c ...... rotype C Moraxella catarrhalis
@nl
type
label
Biological and immunological c ...... rotype C Moraxella catarrhalis
@ast
Biological and immunological c ...... rotype C Moraxella catarrhalis
@en
Biological and immunological c ...... rotype C Moraxella catarrhalis
@nl
prefLabel
Biological and immunological c ...... rotype C Moraxella catarrhalis
@ast
Biological and immunological c ...... rotype C Moraxella catarrhalis
@en
Biological and immunological c ...... rotype C Moraxella catarrhalis
@nl
P2860
P356
P1476
Biological and immunological c ...... rotype C Moraxella catarrhalis
@en
P2093
Shengqing Yu
Xin-Xing Gu
P2860
P304
P356
10.1128/IAI.01915-06
P407
P577
2007-06-01T00:00:00Z